(Additions: Bristol Myers Squibb, Allos, Updates: AstraZeneca, Manchester United)
The following deals, mergers, acquisitions and divestitures were reported at 1430 GMT, Tuesday:
** Bristol Myers Squibb BMY.N said it would buy RayzeBio RYZB.O for about $4.1 billion to bolster its cancer drugs business, marking the second multibillion-dollar deal completed by the drug manufacturer in less than a week.
** AstraZeneca AZN.L said it would buy Gracell Biotechnologies GRCL.O for up to $1.2 billion as the Anglo-Swedish pharmaceutical company pursues its cell therapy ambitions and strengthens its presence in China, the second largest pharmaceutical market in the world.
**Brazilian shopping center operator Allos
ALOS3.SA is ready to sell stakes in several of its shopping centers for a total of 442.8 million reais ($91.32 million), it said in a securities filing.
** Shares in Manchester United MANU.N jumped around 4% after billionaire Jim Ratcliffe’s stake purchase ended months of uncertainty over a deal fans and investors had hoped for that it would revitalize the British football club.
**The Chinese company Fujian Aonong Biological Technology
603363.SS said Dabeinong 002385.SZ had abandoned plans to buy at least 51 percent stake in its controlling shareholder Xiamen Aonong investment.
** Brazilian oil company Enauta said on Monday it had acquired the entire 23% stake held by QatarEnergy Brasil Ltda in some oil fields in the Campos Basin for a total value of $150 million.
**A consortium led by China’s Dazheng Group Acquisition has announced an offer to acquire automation and control technology provider Hollysys Automation Technologies HOLI.F in an all-cash transaction valued at 1.8 billion dollars, according to a press release published Sunday.
** Russian President Vladimir Putin signed a decree on Sunday allowing Rosbank ROSB.MM to acquire stakes in leading Russian companies owned by Société Générale SOGN.PA .